BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 19289476)

  • 41. Care Recommendations for the Investigation and Management of Children With Skeletal Muscle Channelopathies.
    Matthews E; Palace J; Ramdas S; Sansone V; Tristani-Firouzi M; Vicart S; Willis T
    Pediatr Neurol; 2023 Aug; 145():102-111. PubMed ID: 37315339
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The primary periodic paralyses: diagnosis, pathogenesis and treatment.
    Venance SL; Cannon SC; Fialho D; Fontaine B; Hanna MG; Ptacek LJ; Tristani-Firouzi M; Tawil R; Griggs RC;
    Brain; 2006 Jan; 129(Pt 1):8-17. PubMed ID: 16195244
    [TBL] [Abstract][Full Text] [Related]  

  • 43. What the internist should know about hereditary muscle channelopathies.
    Bissay V; Van Malderen SCH
    Acta Clin Belg; 2018 Feb; 73(1):1-6. PubMed ID: 29088983
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Skeletal muscle sodium channelopathies.
    Nicole S; Fontaine B
    Curr Opin Neurol; 2015 Oct; 28(5):508-14. PubMed ID: 26285000
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relevance of tissue specific subunit expression in channelopathies.
    Seitter H; Koschak A
    Neuropharmacology; 2018 Apr; 132():58-70. PubMed ID: 28669898
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Receptor and voltage-operated ion channels in the central nervous system.
    Antkiewicz-Michaluk L
    Pol J Pharmacol; 1995; 47(3):253-64. PubMed ID: 8714758
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical evaluation of membrane excitability in muscle channel disorders: potential applications in clinical trials.
    Cleland JC; Logigian EL
    Neurotherapeutics; 2007 Apr; 4(2):205-15. PubMed ID: 17395130
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ion channels in neuroglial cells.
    Oh Y
    Kaohsiung J Med Sci; 1997 Jan; 13(1):1-9. PubMed ID: 9130817
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Skeletal-muscle channelopathies: periodic paralysis and nondystrophic myotonias.
    Ryan AM; Matthews E; Hanna MG
    Curr Opin Neurol; 2007 Oct; 20(5):558-63. PubMed ID: 17885445
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human skeletal muscle sodium channelopathies.
    Vicart S; Sternberg D; Fontaine B; Meola G
    Neurol Sci; 2005 Oct; 26(4):194-202. PubMed ID: 16193245
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Episodic neurological channelopathies.
    Ryan DP; Ptácek LJ
    Neuron; 2010 Oct; 68(2):282-92. PubMed ID: 20955935
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diagnosis of skeletal muscle channelopathies.
    Spillane J; Fialho D; Hanna MG
    Expert Opin Med Diagn; 2013 Nov; 7(6):517-29. PubMed ID: 24066928
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diseases caused by mutations in ORAI1 and STIM1.
    Lacruz RS; Feske S
    Ann N Y Acad Sci; 2015 Nov; 1356(1):45-79. PubMed ID: 26469693
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ion channels in cultured microglia.
    Walz W; Bekar LK
    Microsc Res Tech; 2001 Jul; 54(1):26-33. PubMed ID: 11526954
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Muscle channelopathies: recent advances in genetics, pathophysiology and therapy.
    Suetterlin K; Männikkö R; Hanna MG
    Curr Opin Neurol; 2014 Oct; 27(5):583-90. PubMed ID: 25188014
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Therapeutic Approaches to Genetic Ion Channelopathies and Perspectives in Drug Discovery.
    Imbrici P; Liantonio A; Camerino GM; De Bellis M; Camerino C; Mele A; Giustino A; Pierno S; De Luca A; Tricarico D; Desaphy JF; Conte D
    Front Pharmacol; 2016; 7():121. PubMed ID: 27242528
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Ion channels].
    Yamashita N
    Nihon Naika Gakkai Zasshi; 1991 Jun; 80(6):941-6. PubMed ID: 1655928
    [No Abstract]   [Full Text] [Related]  

  • 58. Cl⁻ channels: what role do they play in mammalian heart?
    Zhou SS
    Sheng Li Xue Bao; 2006 Apr; 58(2):104-9. PubMed ID: 16628355
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Axonal channelopathies: an evolving concept in the pathogenesis of peripheral nerve disorders.
    Gutmann L; Gutmann L
    Neurology; 1996 Jul; 47(1):18-21. PubMed ID: 8710074
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hallmarks of the channelopathies associated with L-type calcium channels: a focus on the Timothy mutations in Ca(v)1.2 channels.
    Bidaud I; Lory P
    Biochimie; 2011 Dec; 93(12):2080-6. PubMed ID: 21664226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.